Overview
Epithalon (Epitalon, AEDG) is a synthetic tetrapeptide developed as a defined analog related to epithalamin, a pineal polypeptide preparation. The compound is best known in the Khavinson gerontology literature; modern independent human trial evidence is sparse, and the strongest data remain cellular.
Mechanism
The most-cited mechanistic claim is telomere biology. A 2003 paper reported that Epithalon induces telomerase activity and telomere elongation in human somatic cells. Subsequent reviews describe broader gene-expression effects, including promoter interactions and possible neuroendocrine and antioxidant actions. Reviews note the peptide was long treated as a synthetic construct, then reported in physiological pineal extract in 2017. Modern human pharmacokinetics were not retrieved.